DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Tamoxifen therapy
Tamoxifen
Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, hence tamoxifen may be characterized as a mixed agonist/antagonist. It has been the standard endocrine (anti-estrogen) therapy for hormone receptor-positive early breast cancer in pre-menopausal women, although aromatase inhibitors have been proposed. Some breast cancer cells require estrogen to grow. Estrogen binds to and activates the estrogen receptor in these cells...
Tamoxifen therapy - List of case studies
- Infiltrating Duct Carcinoma of Breast
-
were optimal, and therefore the expert recommends hormone therapy. He also recommends to complete the ongoing adjuvant irradiation ... patient should receive at least a 5 year treatment by Tamoxifen switched to aromatase inhibitor . The particulars of this program ...
- Drugs
-
Actinomycin-D and ifosfamide) Adenexae Adjuvant Tamoxifen Adjuvant chemotherapy Adjuvant treatment with Interferon ... Anti-oxidant supplements Anti-platelet therapy Antiangiogenic antibody Avastin Antiarrhythmic treatment ...
- Ovarian Cancer with Metastases
-
confirm the diagnosis? 2. Can you confirm the current therapy? 3. Are there any specialist centres for the diagnosis that was ... ), Gemetabare , Nomafen (20 mg x1), Tamoxifen, Taxol, Gemetabare, Paxol, Caelyx-Oxaliplatin ( Oxilaplatin, ...
- Chronic Atrial Fibrillation in Patient with Prior Hemoptoic Episodes in Bilateral Bronchiectases
-
(PAF) and has been recommended oral anti-coagulant therapy with warfarin (Coumadin). She has mitral regurgitation, and on the ... due to mammary carcinoma with subsequent radiotherapy and Tamoxifen therapy until May 2005. 72 years old - Hospitalization for ...
- Pulmonary heteroplasia
-
Apparently, following one of his suggestions, a therapy with daily 150mg of the EGFR-targeted tyrosin kinase inhibitor ... antiangiogenic therapies ( i.e. daily 40mg tamoxifen plus/minus interferon alpha 3 x 3Mio/week or trofosfamide ...